Investment Summary |
|
|---|---|
| Date | 2007-12-13 |
| Target | Navilyst Medical |
| Sector | Healthcare Services |
| Sellers(s) | Boston Scientific |
| Deal Type | Divestiture |
| Deal Value | 425M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1979 |
| Sector | Medical Products |
| Employees | 48,000 |
| Revenue | 16.7B USD (2024) |
Boston Scientific is a medical technology company that offers products and technologies used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 6 |
| Sector: Healthcare Services M&A | 1 of 2 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 2 of 6 |
| Year: 2007 M&A | 2 of 2 |
| Size (of disclosed) | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-11-05 |
Boston Scientific - Cardiac Surgery & Vascular Surgery Businesses
United States Boston Scientific Corp. - Cardiac Surgery & Vascular Surgery Businesses is a developer of medical technologies designed for use in surgical cardiac procedures, including beating-heart bypass surgery systems and endoscopic vessel harvesting for coronary bypass surgery. |
Sell | $750M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-03-27 |
CryoCor
San Diego, California, United States CryoCor, Inc. is a medical technology company specializing in the use of intracardiac cryotherapy technology. |
Buy | - |
